Stress Reduction in Ovarian Cancer

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

August 9, 2016

Study Completion Date

December 6, 2016

Conditions
Ovarian, Fallopian, and Primary Peritoneal Cancer
Interventions
BEHAVIORAL

Daily stress reduction program

Subjects will participate in activities of a daily stress reduction program.

OTHER

Attention control

Subjects will receive periodic phone calls to review study protocol and will receive stress reduction program materials at the end of the study.

Trial Locations (1)

53792

University of Wisconsin School of Medicine and Public Health, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT01790789 - Stress Reduction in Ovarian Cancer | Biotech Hunter | Biotech Hunter